Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

515 ARTÍCULOS , VIENDO DEL 451 AL 465

Deep Brain Stimulation as an Emerging Therapy for Cognitive Decline in Alzheimer Disease: Systematic Review of Evidence and Current Targets

Picton B, Wong J, Lopez AM, Solomon SS, Andalib S, Brown NJ, Dutta RR, Paff MR, Hsu FP, Oh MY.

World Neurosurg. 2024 Apr;184:253-266.e2. doi: 10.1016/j.wneu.2023.12.083. Epub 2023 Dec 21.

Utility of the Japanese version of the Clinical Dementia Rating® plus National Alzheimer's Coordinating Centre Behaviour and Language Domains for sporadic cases of frontotemporal dementia in Japan

Taomoto D, Sato S, Kanemoto H, Suzuki M, Hirakawa N, Takasaki A, Akimoto M, Satake Y, Koizumi F, Yoshiyama K, Takahashi R, Shigenobu K, Hashimoto M, Miyagawa T, Boeve B, Knopman D, Mori E, Ikeda M.

Psychogeriatrics. 2024 Mar;24(2):281-294. doi: 10.1111/psyg.13072. Epub 2023 Dec 28.

Alzheimer's disease and Alzheimer's disease-related dementias in Hispanics: Identifying influential factors and supporting caregivers

Rawat P, Sehar U, Bisht J, Reddy AP, Reddy PH.

Ageing Res Rev. 2024 Jan;93:102178. doi: 10.1016/j.arr.2023.102178. Epub 2023 Dec 27.

Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis

Zhai Z, Kong F, Zhu Z, Dai J, Cai J, Xie D, Shen Y, Xu Y, Sun T.

Am J Geriatr Psychiatry. 2024 May;32(5):555-583. doi: 10.1016/j.jagp.2023.11.011. Epub 2023 Dec 7.

Novel aspects of the phosphorylation and structure of pathological tau: implications for tauopathy biomarkers

Kimura T, Sato H, Kano M, Tatsumi L, Tomita T.

FEBS Open Bio. 2024 Feb;14(2):181-193. doi: 10.1002/2211-5463.13667. Epub 2023 Jul 8.

ADAM10 as a biomarker for Alzheimer's disease: A systematic review

Oliveira Monteiro E Pereira de Almeida MP, Valle Pedroso R, Mantellatto Grigoli M, Vicente Silva T, Manzine PR, Cominetti MR.

Rev Neurol (Paris). 2024 Jan-Feb;180(1-2):1-11. doi: 10.1016/j.neurol.2023.04.002. Epub 2023 Jul 16.

Non-invasive Biomarkers for Early Detection of Alzheimer's Disease: a New-Age Perspective

Chimthanawala NMA, Haria A, Sathaye S.

Mol Neurobiol. 2024 Jan;61(1):212-223. doi: 10.1007/s12035-023-03578-3. Epub 2023 Aug 19.

Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence

Amidfar M, Askari G, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jan 10;128:110848. doi: 10.1016/j.pnpbp.2023.110848. Epub 2023 Aug 25.

Anti-amyloid antibody treatments for Alzheimer's disease

Perneczky R, Dom G, Chan A, Falkai P, Bassetti C.

Eur J Neurol. 2024 Feb;31(2):e16049. doi: 10.1111/ene.16049. Epub 2023 Sep 11.

The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022

Veitch DP, Weiner MW, Miller M, Aisen PS, Ashford MA, Beckett LA, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Nho KT, Nosheny R, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin A, Shaw LM, Toga AW, Tosun D; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12.

Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network

Wagemann O, Li Y, Hassenstab J, Aschenbrenner AJ, McKay NS, Gordon BA, Benzinger TLS, Xiong C, Cruchaga C, Renton AE, Perrin RJ, Berman SB, Chhatwal JP, Farlow MR, Day GS, Ikeuchi T, Jucker M, Lopera F, Mori H, Noble JM, Sánchez-Valle R, Schofield PR, Morris JC, Daniels A, Levin J, Bateman RJ, McDade E, Llibre-Guerra JJ; Dominantly Inherited Alzheimer Network.

Alzheimers Dement. 2024 Jan;20(1):47-62. doi: 10.1002/alz.13460. Epub 2023 Sep 23.

The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)

Albala B, Appelmans E, Burress R, De Santi S, Devins T, Klein G, Logovinsky V, Novak GP, Ribeiro K, Schmidt ME, Schwarz AJ, Scott D, Shcherbinin S, Siemers E, Travaglia A, Weber CJ, White L, Wolf-Rodda J, Vasanthakumar A.

Alzheimers Dement. 2024 Jan;20(1):695-708. doi: 10.1002/alz.13483. Epub 2023 Sep 29.

Advances in targeted tracking and detection of soluble amyloid-β aggregates as a biomarker of Alzheimer's disease

Gao H, Chen J, Huang Y, Zhao R.

Talanta. 2024 Feb 1;268(Pt 1):125311. doi: 10.1016/j.talanta.2023.125311. Epub 2023 Oct 14.

Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics

Muir RT, Ismail Z, Black SE, Smith EE.

Alzheimers Dement. 2024 Feb;20(2):1436-1458. doi: 10.1002/alz.13510. Epub 2023 Oct 31.

Innovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection

Cournut A, Moustiez P, Coffinier Y, Enjalbal C, Bich C.

Talanta. 2024 Feb 1;268(Pt 2):125357. doi: 10.1016/j.talanta.2023.125357. Epub 2023 Nov 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias